ProCE Banner Activity

Advances in HIV Prevention

Multimedia

Watch and listen as a global panel of expert faculty provides insights on important clinical advances in HIV prevention that have taken place during the past year, including updates in pre-exposure prophylaxis eligibility considerations and regimen selection, the emergence of a new long-acting injectable option, the latest insights on population-specific strategies, expert perspectives on improving equity in access, and broadening prevention strategies for other STIs.

Released: November 04, 2022

Share

Faculty

Gregory Huhn

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Colleen Kelley

Colleen Kelley, MD, MPH

Associate Professor of Medicine
Division of Infectious Diseases
Co-Director
Emory Center for AIDS Research
Emory University
Atlanta, Georgia

Darrell H. S. Tan

Darrell H. S. Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Gregory Huhn, MD, MPHTM: consultant/advisor/speaker: CME Outfitters, Gilead Sciences, Integritas, Janssen, Lilly, Medscape, Merck, Rockpointe, ViiV Healthcare; researcher: Gilead Sciences, Janssen, Lilly, ViiV Healthcare.

Colleen Kelley, MD, MPH

Associate Professor of Medicine
Division of Infectious Diseases
Co-Director
Emory Center for AIDS Research
Emory University
Atlanta, Georgia

Colleen Kelley, MD, MPH: researcher: Gilead Sciences, Moderna, Novavax, ViiV Healthcare.

Darrell H. S. Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Darrell H. S. Tan, MD, FRCPC, PhD: researcher: AbbVie, Gilead Sciences, GlaxoSmithKline.

Additional Information

Program Medium

This program has been made available online.